Agents for the Treatment of Gout: Current Advances and Future Perspectives
Journal of Medicinal Chemistry · 09.11.2023 · 66 (21) · 14474-14493
DOI: 10.1021/acs.jmedchem.3c01710 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 01.11.2023. Verfasst von Xiaoyi Zeng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, PR China. Hauptthemen laut MEDLINE: Gout, Hyperuricemia. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 131 Literaturangaben. Gefördert von: Liaoning Revitalization Talents Program, Shenyang Pharmaceutical University.
Abstract (Originalsprache)
Gout is characterized by hyperuricemia and the deposition of monosodium urate (MSU) crystals around joints. Despite the availability of several drugs on the market, its treatment remains challenging owing to the notable side effects, such as hepatorenal toxicity and cardiovascular complications, that are associated with most existing agents. This perspective aims to summarize the current research progress in the development of antigout agents, particularly focusing on xanthine oxidase (XO) and urate anion transporter 1 (URAT1) inhibitors from a medicinal chemistry viewpoint and their preliminary structure-activity relationships (SARs). This perspective provides valuable insights and theoretical guidance to medicinal chemists for the discovery of antigout agents with novel chemical structures, better efficiency, and lower toxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, PR China.
ORCID-Profile: Mingze Qin
Förderung
- Liaoning Revitalization Talents Program
- Shenyang Pharmaceutical University
Zitieren
APA
Zeng, X., Liu, Y., Fan, Y., Wu, D., Meng, Y., & Qin, M. (2023). Agents for the Treatment of Gout: Current Advances and Future Perspectives. Journal of Medicinal Chemistry, 66(21), 14474-14493. https://doi.org/10.1021/acs.jmedchem.3c01710
Vancouver
Zeng X, Liu Y, Fan Y, Wu D, Meng Y, Qin M. Agents for the Treatment of Gout: Current Advances and Future Perspectives. Journal of Medicinal Chemistry. 2023;66(21):14474-14493. doi:10.1021/acs.jmedchem.3c01710
BibTeX
@article{Zeng2023,
author = {Zeng, Xiaoyi and Liu, Yajing and Fan, Yuxin and Wu, Di and Meng, Yangyang and Qin, Mingze},
title = {Agents for the Treatment of Gout: Current Advances and Future Perspectives},
journal = {Journal of Medicinal Chemistry},
year = {2023},
volume = {66},
number = {21},
pages = {14474--14493},
doi = {10.1021/acs.jmedchem.3c01710}
}
EUVIMED